Circulating extracellular vesicles as biomarkers in the diagnosis, prognosis and therapy of cardiovascular diseases

被引:0
|
作者
Bernath-Nagy, Dominika [1 ,2 ]
Kalinyaprak, Melek Suekran [2 ]
Giannitsis, Evangelos [2 ]
Abraham, Pal [1 ]
Leuschner, Florian [2 ,3 ]
Frey, Norbert [2 ,3 ]
Krohn, Jona Benjamin [2 ,3 ]
机构
[1] Semmelwe Univ, Heart & Vasc Ctr, Budapest, Hungary
[2] Univ Hosp Heidelberg, Dept Cardiol Angiol & Pneumol, Heidelberg, Germany
[3] Heidelberg Univ, German Ctr Cardiovasc Res DZHK, Partner Site Heidelberg Mannheim, Heidelberg, Germany
来源
关键词
extracellular vesicles; cardiovascular disease; diagnosis; prognosis; therapy; biomarker; ATRIAL-FIBRILLATION; EUROPEAN-SOCIETY; MYOCARDIAL-INFARCTION; NONINVASIVE BIOMARKER; INTERNATIONAL SOCIETY; MICRORNA SIGNATURES; POSITION STATEMENT; EJECTION FRACTION; HEART-FAILURE; WORKING GROUP;
D O I
10.3389/fcvm.2024.1425159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease (CVD) ranks among the primary contributors to worldwide mortality. Hence, the importance of constant research on new circulating biomarkers for the improvement of early diagnosis and prognostication of different CVDs and the development and refinement of therapeutic measures is critical. Extracellular vesicles (EV) have a great potential as diagnostic and prognostic markers, as they represent their parent cell by enclosing cell-specific molecules, which can differ in quality and quantity based on cell state. Assuming that all cell types of the cardiovascular system are capable of releasing EV into circulation, an emerging body of evidence has investigated the potential role of serum- or plasma-derived EV in CVD. Comprehensive research has unveiled alterations in EV quantity and EV-bound cargo in the form of RNA, proteins and lipids in the context of common CVDs such as coronary artery disease, atrial fibrillation, heart failure or inflammatory heart diseases, highlighting their diagnostic and prognostic relevance. In numerous in vitro and in vivo models, EV also showed promising therapeutic potential. However, translation of EV studies to a preclinical or clinical setting has proven to be challenging. This review is intended to provide an overview of the most relevant studies in the field of serum or plasma-derived EV.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Prostate cancer-derived extracellular vesicles metabolic biomarkers: Emerging roles for diagnosis and prognosis
    Hamed, Mahmoud Assem
    Wasinger, Valerie
    Wang, Qi
    Graham, Peter
    Malouf, David
    Bucci, Joseph
    Li, Yong
    JOURNAL OF CONTROLLED RELEASE, 2024, 371 : 126 - 145
  • [42] Salivary Extracellular Vesicles: Biomarkers and Beyond in Human Diseases
    Wu, Jialing
    Liu, Gege
    Jia, Rong
    Guo, Jihua
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)
  • [43] Extracellular vesicles as novel biomarkers and pharmaceutic targets of diseases
    Chen, Yanfang
    Tang, Yaoliang
    Fan, Guo-Chang
    Duan, Dayue Darrel
    ACTA PHARMACOLOGICA SINICA, 2018, 39 (04) : 499 - 500
  • [44] Extracellular Vesicles as Biomarkers and Therapeutics for Inflammatory Eye Diseases
    Louie, Henry H.
    Mugisho, Odunayo O.
    Chamley, Lawrence W.
    Rupenthal, Ilva D.
    MOLECULAR PHARMACEUTICS, 2023, 20 (01) : 23 - 40
  • [45] Extracellular vesicles as novel biomarkers and pharmaceutic targets of diseases
    Yanfang Chen
    Yaoliang Tang
    Guo-Chang Fan
    Dayue Darrel Duan
    Acta Pharmacologica Sinica, 2018, 39 : 499 - 500
  • [46] Circulating Extracellular Vesicles as Novel Biomarkers of Cardiovascular Risk in Older Women With Different Sitting Time Patterns
    Chang Ya-Ju
    Avitia, Yesenia
    Godbole, Suneeta
    Bellettiere, John
    Rock, Cheryl L.
    Patterson, Ruth E.
    Jankowska, Marta M.
    Kerr, Jacqueline
    Allison, Matthew A.
    Natarajan, Loki
    Sears, Dorothy D.
    CIRCULATION RESEARCH, 2019, 125
  • [47] Circulating microRNAs: novel biomarkers for cardiovascular diseases
    Xu, Jiahong
    Zhao, Jiangmin
    Evan, Graham
    Xiao, Chunyang
    Cheng, Yan
    Xiao, Junjie
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2012, 90 (08): : 865 - 875
  • [48] Circulating MicroRNAs Biomarkers or Mediators of Cardiovascular Diseases?
    Fichtlscherer, Stephan
    Zeiher, Andreas M.
    Dimmeler, Stefanie
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (11) : 2383 - 2390
  • [49] Circulating microRNAs: novel biomarkers for cardiovascular diseases?
    Dimmeler, Stefanie
    Zeiher, Andreas M.
    EUROPEAN HEART JOURNAL, 2010, 31 (22) : 2705 - 2707
  • [50] Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases
    Tijsen, Anke J.
    Pinto, Yigal M.
    Creemers, Esther E.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2012, 303 (09): : H1085 - H1095